19th November 2014 [Genoa, Italy] - At RSNA 2014 (Radiological Society of North America) ESAOTE will showcase Virtual Navigator fusion imaging. ESAOTE recently received U.S. Food and Drug Administration (FDA) clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound to U.S. customers in addition to other worldwide countries... Also at RSNA 2014 two new ultrasound systems will be showcased - MyLab™Six and MyLab™Gamma - solidifying ESAOTE’s position as the leading innovator in the global ultrasound market, delivering affordable productivity, efficiency and value.